These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12621387)

  • 21. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
    Becquemont L; Verstuyft C; Kerb R; Brinkmann U; Lebot M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice.
    Manford F; Riffo-Vasquez Y; Spina D; Page CP; Hutt AJ; Moore V; Johansson F; Forbes B
    J Pharm Pharmacol; 2008 Oct; 60(10):1305-10. PubMed ID: 18812023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complexity of intestinal absorption and exsorption of digoxin in rats.
    Yao HM; Chiou WL
    Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design.
    Reitman ML; Chu X; Cai X; Yabut J; Venkatasubramanian R; Zajic S; Stone JA; Ding Y; Witter R; Gibson C; Roupe K; Evers R; Wagner JA; Stoch A
    Clin Pharmacol Ther; 2011 Feb; 89(2):234-42. PubMed ID: 21191377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
    Verstuyft C; Strabach S; El-Morabet H; Kerb R; Brinkmann U; Dubert L; Jaillon P; Funck-Brentano C; Trugnan G; Becquemont L
    Clin Pharmacol Ther; 2003 Jan; 73(1):51-60. PubMed ID: 12545143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil.
    Gramatté T; Oertel R
    Clin Pharmacol Ther; 1999 Sep; 66(3):239-45. PubMed ID: 10511059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine.
    Tannergren C; Petri N; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2003 Nov; 74(5):423-36. PubMed ID: 14586383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.
    Burk O; Brenner SS; Hofmann U; Tegude H; Igel S; Schwab M; Eichelbaum M; Alscher MD
    Clin Pharmacol Ther; 2010 Nov; 88(5):685-94. PubMed ID: 20844484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
    Xu YA; Fan G; Gao S; Hong Z
    Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the kinetics of digoxin absorption: enhancement by P-glycoprotein inhibition.
    Weiss M; Sermsappasuk P; Siegmund W
    J Clin Pharmacol; 2012 Mar; 52(3):381-7. PubMed ID: 21343347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells.
    Hansen TS; Nilsen OG
    Phytother Res; 2009 Jan; 23(1):86-91. PubMed ID: 18688789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans.
    Gramatté T; Oertel R; Terhaag B; Kirch W
    Clin Pharmacol Ther; 1996 May; 59(5):541-9. PubMed ID: 8646825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans.
    Glaeser H; Drescher S; Hofmann U; Heinkele G; Somogyi AA; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2004 Sep; 76(3):230-8. PubMed ID: 15371984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
    Tankanow R; Tamer HR; Streetman DS; Smith SG; Welton JL; Annesley T; Aaronson KD; Bleske BE
    J Clin Pharmacol; 2003 Jun; 43(6):637-42. PubMed ID: 12817526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
    Hori R; Okamura N; Aiba T; Tanigawara Y
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein.
    Maezono S; Sugimoto K; Sakamoto K; Ohmori M; Hishikawa S; Mizuta K; Kawarasaki H; Watanabe Y; Fujimura A
    Pediatr Transplant; 2005 Jun; 9(3):315-23. PubMed ID: 15910387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.